封面
市场调查报告书
商品编码
1649510

脑保护系统市场:预测(2025-2030 年)

Cerebral Protection System Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

大脑保护系统市场预计将从 2025 年的 1,033,241,000 美元成长到 2030 年的 1,528,241,000 美元,预测期内的复合年增长率为 8.14%。

全球脑保护系统 (CPS) 市场是一个快速扩展且充满活力的行业,应用于医学研究、诊断和药物开发。脑保护系统,也称为细胞表面抗原或分化标誌簇,是位于细胞外表面充当识别标籤的蛋白质或分子。这些标记物被广泛用于识别、分离和表征各种细胞群,有助于阐明细胞功能和疾病发病机制,并可能确定未来的治疗目标。市场的成长受到多种因素的推动,包括慢性病盛行率的上升、自订治疗需求的增加、流式细胞技术和其他细胞分析技术的进步以及研发活动的投资活性化。

脑保护系统市场驱动因素

  • 心血管疾病的增加:心血管疾病,尤其是主动脉瓣狭窄的发生率不断上升,推动了脑保护系统的需求激增。主动脉瓣狭窄的特征是主动脉瓣变窄,是老化人口的严重问题。这种情况通常需要手术干预,例如经导管主动脉瓣置换术(TAVR),但有导致脑栓塞的风险。因此,对能够降低此类程序流程中风险的 CPS 的需求日益增加。

随着老年人口的增加,与老龄化相关的心血管疾病的发生率也随之增加。许多老年人是 TAVR 等微创手术的理想人选,人们对主动脉瓣狭窄相关併发症的担忧也日益增加。这导致对 CPS 的需求增加,以确保这些手术过程中的病人安全。

地理视角

  • 亚太地区的快速成长:亚太地区的脑保护系统市场正在经历显着成长。主动脉瓣狭窄和冠状动脉疾病等心血管疾病的流行持续推动该地区介入手术的增加。经导管主动脉瓣植入术 (TAVI) 等手术通常利用 CPS 来降低手术过程中发生栓塞事件的风险。

亚太地区的医院采用先进的医疗技术旨在改善病患的治疗效果。将 CPS 整合到心血管护理中表明了对提高患者安全性和降低与这些干预相关的中风和其他神经系统併发症的发生率的决心。

为什么要购买这份报告?

  • 深刻分析:获得深入的市场洞察,涵盖主要和新兴地区,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局:了解全球主要企业所采用的策略策略,并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素:探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议:利用洞察力做出策略决策,在动态环境中开闢新的业务流和收益。
  • 适合广泛用户:对于新兴企业、科学研究机构、顾问公司、中小企业和大型企业来说都是有益且具成本效益的。

它有什么用途?

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 各细分市场及各地区(包括国家)的收益成长及预测分析
  • 公司概况(策略、产品、财务、主要发展等)

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章 脑保护系统市场按类型

  • 介绍
  • 近端过滤器
  • 远端过滤器
  • 导管

第六章 脑保护系统市场(依产品划分)

  • 介绍
  • 红酒哨兵系统
  • Keystone Hearts 三重守护装置
  • Emberla 栓塞导流器

第七章 脑保护系统市场按应用

  • 介绍
  • 医院
  • 其他的

8. 脑保护系统市场(按地区)

  • 介绍
  • 北美洲
    • 按类型
    • 按产品
    • 按应用
    • 按国家
  • 南美洲
    • 按类型
    • 按产品
    • 按应用
    • 按国家
  • 欧洲
    • 按类型
    • 按产品
    • 按应用
    • 按国家
  • 中东和非洲
    • 按类型
    • 按产品
    • 按应用
    • 按国家
  • 亚太地区
    • 按类型
    • 按产品
    • 按应用
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Boston Scientific Corporation
  • Medtronics
  • Edwards Lifesciences
  • InspireMD Inc.
  • Cardiovascular Systems Inc.
  • Kalert
  • Cordis
  • Allium Medical Inc
  • Keystone Heart Ltd
  • NeuroSafe Medical Co. Ltd.
  • Lepu Medical Technology Company
  • Gore Medical
  • Cardinal Health
  • Allium Medica
  • Abbot Laboratories
简介目录
Product Code: KSI061617274

The cerebral protection system market is projected to grow at a CAGR of 8.14% over the forecast period, increasing from US$1,033.241 million in 2025 to US$1,528.241 million by 2030.

The global cerebral protection system (CPS) market is a rapidly expanding and dynamic sector with applications in medical research, diagnostics, and drug development. Cerebral protection systems, also referred to as cell surface antigens or clusters of differentiation markers, are proteins or molecules located on the outer surface of cells that serve as identifying tags. These markers are widely used for identifying, isolating, and characterizing various cell populations, which aids in understanding cell function and disease causation, potentially identifying targets for future therapies. The market's growth is driven by several factors, including the rising prevalence of chronic diseases, increasing demand for custom therapies, advancements in flow cytometry and other cell analysis techniques, and heightened investment in research and development activities.

Drivers of the Cerebral Protection System Market

  • Rising Incidence of Cardiovascular Diseases: The demand for cerebral protection systems has surged due to the increasing prevalence of cardiovascular diseases, particularly aortic stenosis. Aortic stenosis is characterized by the narrowing of the aortic valve, which becomes a significant concern as the population ages. This condition often necessitates surgical interventions such as Transcatheter Aortic Valve Replacement (TAVR), which carry the risk of embolism to the brain. Consequently, there is a growing need for CPS to mitigate these risks during such procedures.

As the elderly population increases, so does the incidence of age-related cardiovascular diseases. Many older individuals are ideal candidates for minimally invasive procedures like TAVR, which raises concerns about complications associated with aortic stenosis. This has led to heightened demand for CPS to ensure patient safety during these interventions.

Geographical Outlook

  • Exponential Growth in Asia Pacific: The Asia Pacific region is experiencing significant growth in the cerebral protection systems market. The prevalence of cardiovascular disorders such as aortic stenosis and coronary artery disease continues to drive an increase in intervention procedures within this region. Procedures like Transcatheter Aortic Valve Implantation (TAVI) commonly utilize CPS to reduce the risk of embolic events during surgery.

The adoption of advanced medical technologies in hospitals across Asia Pacific aims to enhance patient outcomes. The integration of CPS into cardiovascular therapies demonstrates a commitment to improving patient safety and decreasing the incidence of stroke and other neurological complications associated with these interventions.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Cerebral protection system market is segmented and analyzed as follows:

By Type

  • Proximal filter
  • Distal filter
  • Catheter

By Product

  • Clarets Sentinel System
  • Keystone Hearts Triguard Device
  • Umbrella Embolic Deflector

By Application

  • Hospitals
  • Homes
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Taiwan
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. CEREBRAL PROTECTION SYSTEM MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Proximal filter
  • 5.3. Distal filter
  • 5.4. Catheter

6. CEREBRAL PROTECTION SYSTEM MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Clarets Sentinel System
  • 6.3. Keystone Hearts Triguard Device
  • 6.4. Embrella Embolic Deflector

7. CEREBRAL PROTECTION SYSTEM MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Homes
  • 7.4. Others

8. CEREBRAL PROTECTION SYSTEM MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Product
    • 8.3.3. By Application
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Product
    • 8.4.3. By Application
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. UK
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Product
    • 8.5.3. By Application
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Israel
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Product
    • 8.6.3. By Application
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. South Korea
      • 8.6.4.4. India
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Taiwan
      • 8.6.4.7. Thailand
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. Medtronics
  • 10.3. Edwards Lifesciences
  • 10.4. InspireMD Inc.
  • 10.5. Cardiovascular Systems Inc.
  • 10.6. Kalert
  • 10.7. Cordis
  • 10.8. Allium Medical Inc
  • 10.9. Keystone Heart Ltd
  • 10.10. NeuroSafe Medical Co. Ltd.
  • 10.11. Lepu Medical Technology Company
  • 10.12. Gore Medical
  • 10.13. Cardinal Health
  • 10.14. Allium Medica
  • 10.15. Abbot Laboratories